We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Elevance Tops $1B in Housing Investments: What's Driving the Strategy?
Read MoreHide Full Article
Key Takeaways
Elevance Health invested $640M in affordable housing over five years, supporting 2,654 units in 10 states.
The strategy pairs housing with healthcare and support services for vulnerable Medicaid and Medicare members.
Elevance says stable housing may improve outcomes, manage costs and support long-term growth.
Elevance Health, Inc. (ELV - Free Report) recently announced that it has invested $640 million in affordable housing projects over the past five years, reinforcing its broader effort to address social factors that influence health outcomes. The investments supported the development of 2,654 affordable housing units across 15 properties in 10 states, including apartment homes, townhomes and single-family residences. The latest commitment brings ELV's total affordable housing investment to more than $1 billion over nearly two decades, ultimately supporting over 40,000 units across 45 states.
The initiative goes beyond building affordable housing. Elevance aims to pair housing with healthcare and community support services, particularly for vulnerable populations. The company believes that stable housing can improve health outcomes, increase access to care and help address social factors that often lead to poorer health. By helping high-risk Medicaid and Medicare members secure reliable housing, Elevance hopes to create healthier communities and improve member well-being.
The investment also aligns with Elevance's broader strategy of managing healthcare costs while improving member outcomes. For the first quarter of 2026, the company reported adjusted earnings per share of $12.58 and raised its full-year adjusted EPS guidance. As healthcare utilization remains elevated across government-sponsored programs, addressing the root causes of poor health could help moderate medical costs and support long-term margin stability.
The announcement signals a long-term value creation strategy rather than an immediate earnings catalyst. These community-focused investments could strengthen Elevance's relationships with state agencies and enhance its position when competing for government-sponsored healthcare contracts. Overall, the initiative reflects management's focus on sustainable growth and long-term shareholder value.
ELV’s Stock Price Performance
Shares of Elevance Health have gained 11.6% year to date compared to the industry’s 6.5% decline over the same period.
Image Source: Zacks Investment Research
ELV’s Zacks Rank & Key Picks
Elevance Health currently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Surgery Partners’ 2026 earnings is pegged at 36 cents per share, which has witnessed three upward revisions in the past 60 days, with no movement in the opposite direction. The consensus estimate for SGRY’s 2026 revenues is pinned at $3.41 billion, implying 3% year-over-year growth.
The Zacks Consensus Estimate for BrightSpring Health’s 2026 earnings is pegged at $1.67 per share, which has witnessed five upward revisions in the past 60 days, with no movement in the opposite direction. BTSG beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 14.6%. The consensus estimate for 2026 revenues is pinned at $15.05 billion, implying 16.6% year-over-year growth.
The Zacks Consensus Estimate for Alignment Healthcare’s 2026 earnings is pegged at 20 cents per share, which has witnessed four upward revisions in the past 60 days, with no movement in the opposite direction. ALHC beat earnings estimates in each of the trailing four quarters, with the average surprise being 198.8%. The consensus estimate for 2026 revenues is pinned at $5.19 billion, implying 31.4% year-over-year growth.
View the Zacks #1 Rank List
Image: Bigstock
Elevance Tops $1B in Housing Investments: What's Driving the Strategy?
Key Takeaways
Elevance Health, Inc. (ELV - Free Report) recently announced that it has invested $640 million in affordable housing projects over the past five years, reinforcing its broader effort to address social factors that influence health outcomes. The investments supported the development of 2,654 affordable housing units across 15 properties in 10 states, including apartment homes, townhomes and single-family residences. The latest commitment brings ELV's total affordable housing investment to more than $1 billion over nearly two decades, ultimately supporting over 40,000 units across 45 states.
The initiative goes beyond building affordable housing. Elevance aims to pair housing with healthcare and community support services, particularly for vulnerable populations. The company believes that stable housing can improve health outcomes, increase access to care and help address social factors that often lead to poorer health. By helping high-risk Medicaid and Medicare members secure reliable housing, Elevance hopes to create healthier communities and improve member well-being.
The investment also aligns with Elevance's broader strategy of managing healthcare costs while improving member outcomes. For the first quarter of 2026, the company reported adjusted earnings per share of $12.58 and raised its full-year adjusted EPS guidance. As healthcare utilization remains elevated across government-sponsored programs, addressing the root causes of poor health could help moderate medical costs and support long-term margin stability.
The announcement signals a long-term value creation strategy rather than an immediate earnings catalyst. These community-focused investments could strengthen Elevance's relationships with state agencies and enhance its position when competing for government-sponsored healthcare contracts. Overall, the initiative reflects management's focus on sustainable growth and long-term shareholder value.
ELV’s Stock Price Performance
Shares of Elevance Health have gained 11.6% year to date compared to the industry’s 6.5% decline over the same period.
Image Source: Zacks Investment Research
ELV’s Zacks Rank & Key Picks
Elevance Health currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Medical space are Surgery Partners, Inc. (SGRY - Free Report) , BrightSpring Health Services, Inc. (BTSG - Free Report) and Alignment Healthcare, Inc. (ALHC - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Surgery Partners’ 2026 earnings is pegged at 36 cents per share, which has witnessed three upward revisions in the past 60 days, with no movement in the opposite direction. The consensus estimate for SGRY’s 2026 revenues is pinned at $3.41 billion, implying 3% year-over-year growth.
The Zacks Consensus Estimate for BrightSpring Health’s 2026 earnings is pegged at $1.67 per share, which has witnessed five upward revisions in the past 60 days, with no movement in the opposite direction. BTSG beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 14.6%. The consensus estimate for 2026 revenues is pinned at $15.05 billion, implying 16.6% year-over-year growth.
The Zacks Consensus Estimate for Alignment Healthcare’s 2026 earnings is pegged at 20 cents per share, which has witnessed four upward revisions in the past 60 days, with no movement in the opposite direction. ALHC beat earnings estimates in each of the trailing four quarters, with the average surprise being 198.8%. The consensus estimate for 2026 revenues is pinned at $5.19 billion, implying 31.4% year-over-year growth.